TABLE 1.
ID | Chr. | BP a | Gene symbol | Effect | SE | P |
---|---|---|---|---|---|---|
cg10757760 | 2 | 127893054 | 0.0568 | 0.0039 | 6.15 × 10−48 | |
cg04441687 | 11 | 85869322 | 0.0586 | 0.0041 | 1.12 × 10−46 | |
cg26631131 | 19 | 45240591 | 0.0385 | 0.0029 | 1.56 × 10−39 | |
cg02887598 | 2 | 127841945 | BIN1 | −0.0986 | 0.0085 | 2.51 × 10−31 |
cg19116668 | 7 | 99932089 | PMS2L1 | 0.049 | 0.0051 | 1.54 × 10−21 |
cg18959616 | 11 | 85814918 | 0.0656 | 0.0072 | 5.85 × 10−20 | |
cg02521229 | 11 | 60019236 | 0.0658 | 0.0073 | 1.61 × 10−19 | |
cg03579757 | 7 | 100091793 | NYAP1 | 0.0342 | 0.0038 | 2.33 × 10−19 |
cg16618979 | 7 | 143108841 | AC092214.10 | 0.0974 | 0.0109 | 5.11 × 10−19 |
cg03526776 | 6 | 41159608 | TREML2 | −0.0402 | 0.0045 | 7.06 × 10−19 |
cg11461311 | 2 | 127782614 | RP11‐521O16.1;RP11‐521O16.2 | 0.0321 | 0.0036 | 1.31 × 10−18 |
cg00436254 | 2 | 127862614 | BIN1 | 0.0256 | 0.003 | 6.76 × 10−18 |
cg06750524 | 19 | 45409955 | APOE | 0.05 | 0.0059 | 2.18 × 10−17 |
cg23423086 | 11 | 85856245 | −0.0365 | 0.0043 | 2.37 × 10−17 | |
cg22906224 | 7 | 99728672 | AC073842.19 | −0.0392 | 0.0047 | 3.55 × 10−17 |
cg05908241 | 7 | 143109367 | AC092214.10 | 0.0283 | 0.0035 | 6.62 × 10−16 |
cg17830204 | 7 | 99819110 | GATS;PVRIG;STAG3;AC005071.1 | 0.0308 | 0.0039 | 4.78 × 10−15 |
cg19590598 | 2 | 127782813 | RP11‐521O16.1;RP11‐521O16.2 | 0.0282 | 0.0036 | 5.22 × 10−15 |
cg08871934 | 10 | 11720283 | −0.0343 | 0.0044 | 9.59 × 10−15 | |
cg09555818 | 19 | 45449301 | APOC2;APOC4 | −0.0498 | 0.0065 | 1.24 × 10−14 |
Abbreviations: BP, base position; Chr., chromosome; SE, standard error, DMP; differentially methylated position; GRS, genetic risk score.
Base position in genome assembly hg19/GRCh37.